Endocrine Abstracts

Introduction: Obstructive sleep apnoea (OSA) is common in people with type 2 diabetes mellitus (T2DM), with prevalence ranging from 20-50% and up to 85% in obese T2DM. However, OSA remains largely undiagnosed due to the high cost of testing and limited availability of sleep clinics, particularly in developing countries. The aim of this study is to determine the prevalence of type 2 diabetic patients at high risk of OSA and to identify factors associated with OSA in this popula...

Introduction: Obstructive sleep apnoea (OSA) is notably prevalent in individuals with type 2 diabetes (T2D). This syndrome not only elevates cardiovascular risk but is also implicated in the advancement and exacerbation of microangiopathy. The objective of our study was to evaluate the prevalence of diabetic complications in patients with type 2 diabetes who have OSA.Method: A cross-sectional study was conducted on 130 patients with DT2 who were hospital...